Clinical
issues
Explore the intersection of clinical developments and the business of healthcare. From emerging treatments and GLP-1 medications to disease trends, pharmaceutical markets, and drug supply challenges, our insights examine how changes in clinical care influence healthcare costs, patient access, utilization, and organizational strategy.
Clinical issues articles
15 items
Analysis
Can AI help close a persistent gap in cardiovascular care?
An exploration of a persistent demographic gap in cardiovascular care (under diagnosis in women) and the way AI is being used to try to close the gap.
Brandon Aylward
10 min read
Explainers
What’s next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care
GLP-1 innovation is reshaping modern medicine, from new drug designs and expanded indications to smarter manufacturing, coverage, and digital integration.
Brandon Aylward
15 min read
Explainers
Specialty value-based care: The next phase of VBC
Explore specialty value-based care (VBC), the next phase of VBC. Discover how specialty VBC is transforming healthcare with high-quality, cost-effective solutions.
Jordan Peterson
7 min read
Explainers
Checking in on Make America Healthy Again, pt. 2: MAHA and the future of preventive care
This post focused on the intersection between MAHA and the future of preventive care: how the Make America Healthy Again initiative is reshaping primary care and food policy.
Yulan Egan
8 min read
Explainers
Checking in on Make America Healthy Again: MAHA and vaccines
The MAHA agenda is advancing quickly. This post covers where the focus has been, and dive into the area that has seen the most action to date: MAHA and vaccines.
Yulan Egan
8 min read
Analysis
5 ambulatory specialty trends to watch
This post lays out 5 top ambulatory specialty trends, covering current issues and developments among ambulatory surgery centers (ASCs), infusion centers, and medical groups that perform in-office procedures.
Amanda Berra
9 min read
Analysis
Key company profiles: CVS Health’s approach to vertical integration
The healthcare industry has been experiencing a wave of vertical consolidation. This post details CVS Health's approach to vertical integration.
Yulan Egan
10 min read
Explainers
The eight factors that will determine the impact of GLP-1s
Sizing the full, eventual impact of GLP-1s is difficult—here are the eight factors that will determine the size of their impact.
Yulan Egan
7 min read
Explainers
The promise and peril of GLP-1 agonists: What we do (and don’t) know as of August 2024
Discover the latest on GLP-1 agonists: from their unprecedented weight-loss effects to potential risks, and more as of August 2024.
Yulan Egan
9 min read